At the 11th Annual Spine, Orthopedic & Pain Management-Driven ASC Conference on June 14, Kenneth Pettine, MD, founder of The Spine Institute, presented on stem cell treatments in a session titled “The Latest Development in Stem Cell Treatments as Applied to Spine.” Dr. Pettine shared his research outcomes from mesenchymal stem cell therapy derived from autologous bone marrow concentrate and placental matrix. His FDA-approved studies included injecting lumbar spine discs for discogenic back pain, as well as into various joints.
MSCs are pluripotent cells that can become fibroblasts, osteoblasts or chrondroblasts. Under certain FDA guidelines, the use of MSCs is not restricted. “As long as you do it in a way that you are minimally manipulating the cells and put them in at the point of care, there are no FDA issues,” Dr. Pettine said.
Cellular therapies use living cells to treat injuries and promote natural healing, he said. This treatment harnesses the natural healing potential of stem cells with no reports of adverse effects.
Dr. Pettine detailed his process of injecting stem cells into a patient, which includes taking bone marrow from the ilium, putting it in a centrifuge and taking the separated layer that includes MSCs. The entire process takes about 30 minutes and nearly all of his patients saw drastic improvements in their pain intensity scores.
Dr. Pettine continues to pursue stem cell studies and applications and is currently conduct a study on former NFL players with hip and knee osteoarthritis.
MSCs are pluripotent cells that can become fibroblasts, osteoblasts or chrondroblasts. Under certain FDA guidelines, the use of MSCs is not restricted. “As long as you do it in a way that you are minimally manipulating the cells and put them in at the point of care, there are no FDA issues,” Dr. Pettine said.
Cellular therapies use living cells to treat injuries and promote natural healing, he said. This treatment harnesses the natural healing potential of stem cells with no reports of adverse effects.
Dr. Pettine detailed his process of injecting stem cells into a patient, which includes taking bone marrow from the ilium, putting it in a centrifuge and taking the separated layer that includes MSCs. The entire process takes about 30 minutes and nearly all of his patients saw drastic improvements in their pain intensity scores.
Dr. Pettine continues to pursue stem cell studies and applications and is currently conduct a study on former NFL players with hip and knee osteoarthritis.